Massimo Cristofanilli, MDEnriched profile
Professor of Medicine; Director of Breast Medical Oncology, Division of Hematology and Medical Oncology; Associate Director of Precision Oncology, Sandra and Edward Meyer Cancer Center; Scientific Director, Englander Institute for Precision Medicine · Cornell University
Overview
Updated 14 Jul 2026
Massimo Cristofanilli, M.D., is Professor of Medicine at Weill Cornell Medicine (Weill Cornell Medical College), Cornell University -- New York, NY; attending physician, NewYork-Presbyterian Hospital. The public record shows 1,440 publications with 58,293 citations (h-index 112), centered on Cancer Cells and Metastasis, Cancer Genomics and Diagnostics, Advanced Breast Cancer Therapies. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 19 companies.
- Most recent indexed publication: 2026 · Journal of clinical oncology
- Top research focus: Cancer Cells and Metastasis
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 19 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 25 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 436.
Clinical & industrytrials, payments and federal funding
Federally funded research awards.
Public positionssourced statements on record
- Presenter at FDA Oncologic Drugs Advisory Committee (ODAC) meeting
April 30, 2026, on ESR1 mutations in HR+/HER2- breast cancer and unmet need …
2026verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- SGT-53, Carboplatin, and Pembrolizumab for the Treatment of Metastatic Triple Negative Inflammatory Breast Cancer
Sponsor: Northwestern University
InvestigatorPhase 1WithdrawnNCT05093387 - Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial
Sponsor: Massachusetts General Hospital
InvestigatorPhase 2RecruitingNCT03990896 - Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
Sponsor: National Cancer Institute (NCI)
InvestigatorPhase 2RecruitingNCT03606967
Industry payments
Updated 14 Jul 2026
19 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- AstraZeneca UK LimitedProgram year202512 payments$38,315openpaymentsdata.cms.gov ↗
- Merck Sharp & Dohme LLCProgram year20259 payments$10,625openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year20254 payments
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Dual-positive CTCs in patients with advanced breast cancer show metastatic potential and prognostic value.
Science translational medicine
2026
Most-cited worksby citation count (OpenAlex)
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.nyp.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.nyp.org ↗
- Internal Medicine Residency
Cabrini Medical Center, New York
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗ - Medical Oncology Fellowship
The University of Texas MD Anderson Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗ - Medical Oncology Fellowship
La Sapienza University, Rome
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗
Editorial & leadership rolesjournal and society appointments
- Director of Breast Medical Oncology
Division of Hematology and Medical Oncology, Weill Cornell Medicine
2021verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.weill.cornell.edu ↗ - Associate Director of Precision Oncology
Sandra and Edward Meyer Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗ - Co-leader
Meyer Cancer Center Breast Cancer Disease Management Team
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗
Awards & honorshonors on the public record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →fda.gov ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →fda.gov ↗
Secondary affiliationsappointments beyond the home institution
- Co-founder and Past President (2021-2025 term)
International Society of Liquid Biopsy (ISLB); current president as of 2025-2029 term is Umberto Malapelle
2029provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →islb.info ↗ - Attending Physician
NewYork-Presbyterian Hospital / Weill Cornell Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.nyp.org ↗ - Former Professor of Medicine and Associate Director of Translational Research/Precision Medicine
Robert H. Lurie Comprehensive Cancer Center …
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.weill.cornell.edu ↗
- CancerCast podcast episode "Liquid Biopsy – Cancer's Clues in the Blood," with Dr. Manish Shah
Weill Cornell Medicine
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.weill.cornell.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/massimo-cristofanilli-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/massimo-cristofanilli-md-facp-76a56115
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
vivo.weill.cornell.edu/display/cwid-mac9795
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vivo.weill.cornell.edu ↗
Mentions by otherswhere others cite or feature them
- Other
weillcornell.org/massimo-cristofanilli-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗ - Other
weillcornell.org/news/podcast-liquid-biopsy-%E2%80%93-cancer%E2%80%99s-clues-in-the-blood
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗ - Spotify
open.spotify.com/episode/6U9rw6Vg547PieVdOSdG75
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →open.spotify.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Shahrokh Shariat, MD
Cornell University
- 2,879
- publications
- 147
- h-index
- 6
- trials
Robert Harrington, MD
Cornell University
- 1,021
- publications
- 124
- h-index
- 6
- trials
Giuseppe Giaccone, MD, PhD
Cornell University
- 1,118
- publications
- 130
- h-index
- 19
- trials
Silvia Formenti, MD
Cornell University
- 680
- publications
- 89
- h-index
- 21
- trials